Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:694703.
doi: 10.1100/2012/694703. Epub 2012 Aug 1.

Effects of repetitive hyperbaric oxygen treatment in patients with acute cerebral infarction: a pilot study

Affiliations

Effects of repetitive hyperbaric oxygen treatment in patients with acute cerebral infarction: a pilot study

Cheng-Hsin Chen et al. ScientificWorldJournal. 2012.

Abstract

The role of hyperbaric oxygen therapy (HBOT) in the treatment of acute ischemic stroke is controversial. This prospective study assessed the efficacy and safety of HBOT as adjuvant treatment on 46 acute ischemic stroke in patients who did not receive thrombolytic therapy. The HBOT group (n = 16) received conventional medical treatment with 10 sessions of adjunctive HBOT within 3-5 days after stroke onset, while the control group (n = 30) received the same treatment but without HBOT. Early (around two weeks after onset) and late (one month after onset) outcomes (National Institutes of Health Stroke Scale, NIHSS scores) and efficacy (changes of NIHSS scores) of HBOT were evaluated. The baseline clinical characteristics were similar in both groups. Both early and late outcomes of the HBOT group showed significant difference (P ≤ 0.001). In the control group, there was only significant difference in early outcome (P = 0.004). For early efficacy, there was no difference when comparing changes of NIHSS scores between the two groups (P = 0.140) but there was statistically significant difference when comparing changes of NIHSS scores at one month (P ≤ 0.001). The HBOT used in this study may be effective for patients with acute ischemic stroke and is a safe and harmless adjunctive treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hyperbaric oxygen therapy in acute ischemic stroke trial.
Figure 2
Figure 2
The clinical outcome (NIHSS score) in the HBOT group. The NIHSS scores were significantly decreased immediately after HBOT and after one month compared to the scores before HBOT (P < 0.001).
Figure 3
Figure 3
The clinical outcome (NIHSS score) in the control group. The NIHSS scores were significantly decreased on the 10th day after stroke (P < 0.05) but without any difference after one month (P = 0.054).
Figure 4
Figure 4
The change of NIHSS scores in both groups. There was no significant NIHSS change on the 10th day after stroke (P = 0.140) but there was significant difference after one month (P = 0.024).

References

    1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine. 1995;333(24):1581–1587. - PubMed
    1. Chen WH, Lin HS, Chen CI, Chou MS, Liou CW. The medico-legal issue of tissue plasminogen activator in ischemic stroke: a review of judiciary decrees in Taiwan. Acta Neurologica Taiwanica. 2011;20:163–171. - PubMed
    1. Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. American Journal of Respiratory and Critical Care Medicine. 2007;176(5):491–497. - PubMed
    1. Zhang JH. Editorial: hyperbaric oxygen in neurological diseases. Neurological Research. 2007;29(2):113–115. - PubMed
    1. Kalani M, Jörneskog G, Naderi N, Lind F, Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers—long-term follow-up. Journal of Diabetes and Its Complications. 2002;16(2):153–158. - PubMed

Publication types

LinkOut - more resources